Phase 3 Hematologic Neoplasm Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Influenza Vaccination Strategy for Patients With Hematologic Malignancy

Hematologic NeoplasmsInfluenzaImmunogenicity

Asan Medical Center60 enrolled1 locationNCT07485855

Recruiting

Phase 3

Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)

Hematologic Neoplasms

Ottawa Hospital Research Institute662 enrolled12 locationsNCT04448184